Skip to main content

Advertisement

Log in

MIGRAINE

Identifying molecular targets in trigeminal nociception

  • News & Views
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

A new paper published in Neuron presents an analysis of mRNA expression in human and mouse trigeminal ganglia at single-nucleus resolution. The resulting resource is thought-provoking and suggests new targets for pain therapies; however, the findings should be interpreted in the context of the available protein data and warrant functional verification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Stovner, L. J. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27, 193–210 (2007).

    Article  Google Scholar 

  2. Edvinsson, L. & Haanes, K. A. Identifying new antimigraine targets: lessons from molecular biology. Trends Pharmacol. Sci. 42, 217–225 (2021).

    Article  CAS  Google Scholar 

  3. Yang, L. et al. Human and mouse trigeminal ganglia cell atlas implicates multiple cell types in migraine. Neuron https://doi.org/10.1016/j.neuron.2022.03.003 (2022).

  4. Grindberg, R. V. et al. RNA-sequencing from single nuclei. Proc. Natl Acad. Sci. USA 110, 19802–19807 (2013).

    Article  CAS  Google Scholar 

  5. Edvinsson, J. C. et al. Neurokinins and their receptors in the rat trigeminal system: differential localization and release with implications for migraine pain. Mol. Pain 17, 17448069211059400 (2021).

    Article  CAS  Google Scholar 

  6. Edvinsson, J. C. A., Haanes, K. A. & Edvinsson, L. Neuropeptides and the nodes of ranvier in cranial headaches. Front. Physiol. 12, 820037 (2022).

    Article  Google Scholar 

  7. Edvinsson, L., Grell, A. S. & Warfvinge, K. Expression of the CGRP family of neuropeptides and their receptors in the trigeminal ganglion. J. Mol. Neurosci. 70, 930–944 (2020).

    Article  CAS  Google Scholar 

  8. Edvinsson, J. C. A. et al. Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system. Cephalalgia 40, 1296–1309 (2020).

    Article  Google Scholar 

  9. Schytz, H. W. et al. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132, 16–25 (2009).

    Article  Google Scholar 

  10. Ashina, M. et al. A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention. Cephalalgia 41, 33–44 (2021).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lars Edvinsson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edvinsson, L., Edvinsson, J.C.A. & Haanes, K.A. Identifying molecular targets in trigeminal nociception. Nat Rev Neurol 18, 385–386 (2022). https://doi.org/10.1038/s41582-022-00671-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-022-00671-4

  • Springer Nature Limited

Navigation